BUSINESS
Mitsubishi Tanabe Staffers Tapping New Support System to Balance Work and Infertility, Medical Treatment
January 18, 2019
More and more employees of Mitsubishi Tanabe Pharma are taking advantage of the company’s support system to balance work and medical care introduced last October, with several already applying for its use for infertility treatments,…

LATEST

January 18, 2019
It is important to always use insulin when Astellas Pharma’s SGLT2 inhibitor Suglat (ipragliflozin), which was approved for an additional indication of type 1 diabetes late last month, is given to type 1 diabetes patients,…
January 18, 2019
The health ministry’s de-facto decision-making body for drug approval will review Zeria Pharmaceutical’s iron deficiency treatment ferric carboxymaltose on January 31, but is skipping discussions on Shionogi’s ADHD drug lisdexamfetamine dimesylate, which was put on hold at the last meeting…
January 18, 2019
Japan’s ethical drug sales inched down 0.2% in November versus the same month the previous year on a wholesaler shipment basis, according to a flash report released by Crecon Research & Consulting. The reporting month had one more business day…
By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…

Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

NEWS CATEGORY

REGULATORY

BUSINESS

ORGANIZATION

ACADEMIA